NCT00323544View on ClinicalTrials.gov

SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

June 30, 2007

Study Completion Date

October 31, 2007

Conditions
HIV Infections
Interventions
DRUG

zidovudine and lamivudine (Combivir®)

DRUG

emtricitabine and tenofovir DF

Trial Locations (1)

CB1 6GT

Gilead Sciences, Cambridge

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY